10 /100
LOW RISK
Score updated Jul 13, 2026

CPRX — Catalyst Pharmaceuticals, Inc. Dilution Risk Tracker

Track CPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CPRX — Get alerts when the score changes →

As of July 13, 2026, Catalyst Pharmaceuticals, Inc. (CPRX) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Catalyst Pharmaceuticals, Inc. has a market capitalization of $3.82B, 122.38M shares outstanding, 385 institutional holders tracked. Key dilution vectors include 1.20M outstanding warrants, approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CPRX.
🔔 Track CPRX — Get forecast alerts →

💹 Market Data

Market Cap$3.82B
Shares Outstanding122.38M
Float115.58M
Cash$755.86M
Debt$2.68M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.3% shares (2026Q1 vs prior)
385 institutional holders · 121.60M shares
#1 BlackRock, Inc. 18.77M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 10.25M shares
#3 MORGAN STANLEY 7.46M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest7.85M
Days to Cover3.3
% of Float6.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2017
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CPRX Shareholders

Catalyst Pharmaceuticals, Inc. (CPRX) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch tracks 1.2M outstanding warrants for CPRX. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for CPRX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CPRX alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track CPRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CPRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CPRX
📊 CPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CPRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.